Overall verdict
Buy
7.9/10
1-year performance
+63.35%
Score breakdown
Up 63.3% over 1 year, 79% of the 52-week range.
Strongest: Financial strength 10.0/10. Weakest: Shareholder return 5.0/10.
11 analysts, target +0.2% vs the price.
Oscar Health, Inc. operates as a healthcare technology company in the United States. The company offers health plans to individuals, families, employees, and small group markets. It also provides +Oscar platform that power others throughout the healthcare system; Campaign Builder platform, an engagement and recommendation platform for providers and payors; and reinsurance products.
In addition, the company offers brokerage services and enrollment platform for brokers and consumers to shop, buy, and enroll in medical and supplemental health products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.
Sector
Financials
Industry
Insurance
Primary listing
Nyse
United States
CEO
Mark Bertolini
Founded
2012
Employees
2 305
Revenue / employee
5.1M USD
Next earnings
November 6, 2026 (estimated)
Institutional holders
- BlackRock, Inc.7.28%
- T. Rowe Price Investment Management, Inc.4.61%
- D. E. Shaw & Co., Inc.4.47%
- VANGUARD PORTFOLIO MANAGEMENT LLC3.90%
- VANGUARD CAPITAL MANAGEMENT LLC3.74%
- AMERICAN CENTURY COMPANIES INC3.20%
- CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM2.76%
- JANE STREET GROUP, LLC2.25%
- Thrive Capital Management, LLC2.24%
- Other institutions38.26%
- Rest of the register27.31%
402 13F filings as of June 30, 2026: US managers above $100M, filed up to 45 days after quarter end. No insiders, no retail. A share on loan is declared by its lender and by whoever bought it from the short seller, so the total can exceed 100%.
Research uses the underlying stock’s market history. The purchase quote is calculated separately when you review your order.
52-week high
34.48 USD
52-week low
10.69 USD
1-year performance
63.35%
Rising
Year-to-date performance
111.28%
Rising
Drawdown
-14.43%
Mild pullback
Position in the 52-week range
79% of range
Range: 31.55 USD - 32.05 USD (2 methods agree)
The price implies growth of -30.00% per year; the company grows at 25.00%.
Net margin 3.6%, ROIC 27.9%, ROE 34.3%.
Net margin
3.60%
Low
Sector 6.02%|S&P 12.97%
Gross margin
—
Return on equity (ROE)
34.31%
Exceptional
Sector 12.93%|S&P 16.52%
Return on invested capital (ROIC)
27.94%
Exceptional
Free cash flow margin (FCF)
28.59%
Exceptional
Profit-to-cash conversion (FCF conversion)
7.95x
Exceptional
Margin stability
11.0 pts
Very uneven
Revenue to net income
Growth
9.5/10Revenue up 70.4% over 1 year, 90.8% a year over 5.
Revenue (trailing 12 months)
15.3Md USD
Revenue growth (1y)
70.40%
Hyper-growth
Revenue growth (3y)
195.22%
Hyper-growth
EPS growth (1y)
—
EPS CAGR (5y)
—
EPS revisions (3 months)
80.75%
Sharply revised up
Valuation
7.0/10P/E 21.5x, forward P/E 15.6x, EV/EBITDA 13.3x, PEG 0.10. The multiple sits in the 75th percentile of its own 5-year history.
P/E (TTM)
21.5x
Expensive
Sector 16.3x|S&P 23.0x
Forward P/E
15.6x
Expensive
EV / EBITDA
13.3x
Cheap
Sector 56.8x|S&P 14.5x
PEG
0.10
Growth unpriced
Sector 0.23|S&P 0.86
Fair value (reverse DCF)
31.80 USD
Fairly priced
P/E vs its own 5-year history
among the 25% highest valuations
Pricier than usual
Market cap
8.3Md USD
Financial strength
10.0/10Cash covers 944.2% of the debt, no net debt (net cash).
Net debt / EBITDA
—
Gearing (net debt / equity)
-177.31%
Net cash
Cash
4.1Md USD
Cash / market cap
48.82%
Very solid
Cash / total debt
944.24%
Net cash
Interest coverage
39.7x
Very solid
Net debt
-3.6Md USD
Equity
2.1Md USD
Closed daily candles, 2 years
Last close on September 24, 2026: 28.87 USD
- MM2031.47
- MM5030.68
- MM20021.51
- RSI 1437.7
Top panel: closed candles, 20, 50 and 200-day moving averages, with volume in grey. Bottom panel: 14-day RSI with dashed 30 and 70 levels.
200-day average slope, 1 month
+8.32%
200-day average slope, 3 months
+22.46%
50-day average slope, 1 month
+1.97%
Price structure
higher-low
Bullish RSI divergence
No
20-day volatility
2.78 % per day
Volatility change
-29.91%
Forecasts by fiscal year
| Fiscal year | EPS | Normalised EPS | Revenue | EBITDA | Net income |
|---|---|---|---|---|---|
| 2026 | 1.89 (7) | 1.91 (8) | 18 732 (10) | 804 (9) | 655 (5) |
| 2027 | 2.15 (7) | 2.17 (8) | 20 795 (10) | 996 (9) | 733 (5) |
Amounts in millions of USD, EPS in USD per share. In brackets, the number of analysts. Consensus as of September 23, 2026.
Same sub-industry: 78 companies behind the medians.
| # | Company | Code | Country | Overall / 10 | Fundamentals / 10 | Mkt cap | P/E | Net margin | Revenue growth | ROIC | Net debt / EBITDA | FCF yield | 1-year perf. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | OSCR | 7.9 | 8.1 | 8.3Md USD | 21.5x | 3.6 % | 70.4 % | 27.9 % | — | 52.5 % | 63.3 % | ||
| 2 | 601318 | 7.7 | N/A | 136Md USD | — | — | 6.5 % | — | — | — | -3.7 % | ||
| 3 | 2628 | 7.6 | 8.7 | 148Md USD | 3.0x | 41.3 % | 36.2 % | 39.0 % | — | 65.0 % | -1.3 % | ||
| 4 | MFC | 6.8 | 6.6 | 72.3Md USD | 16.6x | 10.0 % | 28.2 % | 10.2 % | — | 29.9 % | 42.9 % | ||
| 5 | MET | 6.6 | 6.0 | 61.8Md USD | 18.6x | 4.6 % | 11.4 % | 7.5 % | — | 26.8 % | 21.0 % | ||
| 6 | GWO | 5.6 | 4.8 | 58.8Md USD | 19.1x | 9.5 % | 21.4 % | 11.7 % | — | 5.0 % | 68.8 % | ||
| 7 | AFL | 5.4 | 5.8 | 57.8Md USD | 12.3x | 26.9 % | -1.0 % | 13.1 % | — | 4.6 % | 5.4 % | ||
| 8 | 2881 | 5.4 | 4.6 | 67.3Md USD | 12.9x | 18.1 % | -2.8 % | 10.8 % | — | -9.8 % | 73.3 % | ||
| 9 | 1299 | 4.7 | 4.7 | 99.4Md USD | 12.7x | 23.2 % | 10.0 % | 14.6 % | — | 1.4 % | 4.0 % |
